BioWorld - Wednesday, February 11, 2026

BioWorld Science

June 11, 2021

View Archived Issues

Phase I data presented for SHR-1701 in patients with NSCLC

Read More

Enrollment opens in phase IIa study of FM-101 for NAFLD and NASH

Read More

Preclinical data reported on MigVax-101 subunit oral vaccine for COVID-19

Read More

Spark Therapeutics patents compositions for secretable protein-induced immune tolerization

Read More

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

Read More

Yuhan Corp., Green Cross Corp. present new GLCT-1 inhibitors

Read More

Zhejiang Hisun Pharmaceutical divulges new RET and/or VEGFR-2 inhibitors

Read More

New HBV HBsAg secretion inhibitors synthesized at Arbutus Biopharma

Read More

Penpulimab is highly active in relapsed/refractory classical Hodgkin's lymphoma

Read More

Targovax presents 24-month data from phase I/II study of ONCOS-102 in mesothelioma

Read More

China's NMPA approves clinical trial application for sirolimus for injection (albumin-bound)

Read More

First patient dosed in phase I study of CID-103 in multiple myeloma

Read More

Sovateltide slows down the progression of Alzheimer's disease in phase II study

Read More

Berdazimer sodium shows promising efficacy in preclinical SARS-CoV-2 transmission model

Read More

Vor Biopharma and Abound Bio partner to develop multi-targeted CAR-Ts

Read More

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

Read More

Phase I data for seclidemstat in R/R Ewing sarcoma

Read More

Myelin renewal reverses AD cognitive dysfunction in mice

Read More

Circulating markers of collagen turnover tied to disease severity in ADPKD

Read More

Phase II proof-of-concept study of VX-864 in AATD meets primary endpoint

Read More

HiberCell begins phase Ia study of PERK inhibitor HC-5404-FU in metastatic solid tumors

Read More